Table of Content
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Vaccine Adjuvants Market, by Type
1.4.2 Europe Vaccine Adjuvants Market, by Administration
1.4.3 Europe Vaccine Adjuvants Market, by Application
1.4.4 Europe Vaccine Adjuvants Market, by Country
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
Chapter 4. Competition Analysis - Global
4.1 KBV Cardinal Matrix
4.2 Recent Industry Wide Strategic Developments
4.2.1 Partnerships, Collaborations and Agreements
4.2.2 Product Launches and Product Expansions
4.2.3 Acquisition and Mergers
4.2.4 Trials and Approvals
4.3 Top Winning Strategies
4.3.1 Key Leading Strategies: Percentage Distribution (2019-2023)
4.3.2 Key Strategic Move: (Partnerships, Collaborations & Agreements: 2020, Feb – 2023, Oct) Leading Players
4.4 Porter Five Forces Analysis
Chapter 5. Europe Vaccine Adjuvants Market, by Type
5.1 Europe Particulate Market, by Country
5.2 Europe Adjuvant Emulsion Market, by Country
5.3 Europe Pathogen Market, by Country
5.4 Europe Combination Market, by Country
5.5 Europe Others Market, by Country
Chapter 6. Europe Vaccine Adjuvants Market, by Administration
6.1 Europe Intramuscular Market, by Country
6.2 Europe Intranasal Market, by Country
6.3 Europe Oral Market, by Country
6.4 Europe Intradermal Market, by Country
6.5 Europe Others Market, by Country
Chapter 7. Europe Vaccine Adjuvants Market, by Application
7.1 Europe Infectious Diseases Market, by Country
7.2 Europe Cancer Market, by Country
7.3 Europe Others Market, by Country
Chapter 8. Europe Vaccine Adjuvants Market, by Country
8.1 Germany Vaccine Adjuvants Market
8.1.1 Germany Vaccine Adjuvants Market, by Type
8.1.2 Germany Vaccine Adjuvants Market, by Administration
8.1.3 Germany Vaccine Adjuvants Market, by Application
8.2 UK Vaccine Adjuvants Market
8.2.1 UK Vaccine Adjuvants Market, by Type
8.2.2 UK Vaccine Adjuvants Market, by Administration
8.2.3 UK Vaccine Adjuvants Market, by Application
8.3 France Vaccine Adjuvants Market
8.3.1 France Vaccine Adjuvants Market, by Type
8.3.2 France Vaccine Adjuvants Market, by Administration
8.3.3 France Vaccine Adjuvants Market, by Application
8.4 Russia Vaccine Adjuvants Market
8.4.1 Russia Vaccine Adjuvants Market, by Type
8.4.2 Russia Vaccine Adjuvants Market, by Administration
8.4.3 Russia Vaccine Adjuvants Market, by Application
8.5 Spain Vaccine Adjuvants Market
8.5.1 Spain Vaccine Adjuvants Market, by Type
8.5.2 Spain Vaccine Adjuvants Market, by Administration
8.5.3 Spain Vaccine Adjuvants Market, by Application
8.6 Italy Vaccine Adjuvants Market
8.6.1 Italy Vaccine Adjuvants Market, by Type
8.6.2 Italy Vaccine Adjuvants Market, by Administration
8.6.3 Italy Vaccine Adjuvants Market, by Application
8.7 Rest of Europe Vaccine Adjuvants Market
8.7.1 Rest of Europe Vaccine Adjuvants Market, by Type
8.7.2 Rest of Europe Vaccine Adjuvants Market, by Administration
8.7.3 Rest of Europe Vaccine Adjuvants Market, by Application
Chapter 9. Company Profiles
9.1 Novavax, Inc.
9.1.1 Company Overview
9.1.2 Financial Analysis
9.1.3 Segmental and Regional Analysis
9.1.4 Research & Development Expenses
9.1.5 Recent strategies and developments:
9.1.5.1 Partnerships, Collaborations, and Agreements:
9.1.6 SWOT Analysis
9.2 SPI Pharma, Inc. (Associated British Foods PLC)
9.2.1 Company Overview
9.2.2 Financial Analysis
9.2.3 Segmental and Regional Analysis
9.2.4 Research & Development Expenses
9.2.5 Recent strategies and developments:
9.2.5.1 Partnerships, Collaborations, and Agreements:
9.3 Agenus Inc.
9.3.1 Company Overview
9.3.2 Financial Analysis
9.3.3 Regional Analysis
9.3.4 Research & Development Expenses
9.3.5 Recent strategies and developments:
9.3.5.1 Partnerships, Collaborations, and Agreements:
9.3.6 SWOT Analysis
9.4 InvivoGen SAS
9.4.1 Company Overview
9.4.2 SWOT Analysis
9.5 Seppic S.A. (L’Air Liquide S.A.)
9.5.1 Company Overview
9.5.2 Financial Analysis
9.5.3 Segmental and Regional Analysis
9.5.4 Research & Development Expenses
9.5.5 Recent strategies and developments:
9.5.5.1 Product Launches and Product Expansions:
9.5.6 SWOT Analysis
9.6 Riboxx GmbH
9.6.1 Company Overview
9.7 GlaxoSmithKline PLC (GSK)
9.7.1 Company Overview
9.7.2 Financial Analysis
9.7.3 Regional Analysis
9.7.4 Research & Development Expense
9.7.5 Recent strategies and developments:
9.7.5.1 Partnerships, Collaborations, and Agreements:
9.7.5.2 Product Launches and Product Expansions:
9.7.5.3 Trials and Approvals:
9.7.6 SWOT Analysis
9.8 CSL Limited
9.8.1 Company Overview
9.8.2 Financial Analysis
9.8.3 Segmental and Regional Analysis
9.8.4 Research & Development Expenses
9.8.5 Recent strategies and developments:
9.8.5.1 Partnerships, Collaborations, and Agreements:
9.8.6 SWOT Analysis
9.9 Croda International PLC
9.9.1 Company Overview
9.9.2 Financial Analysis
9.9.3 Segmental and Regional Analysis
9.9.4 Recent strategies and developments:
9.9.4.1 Partnerships, Collaborations, and Agreements:
9.9.4.2 Acquisition and Mergers:
9.10. Merck & Co., Inc.
9.10.1 Company Overview
9.10.2 Financial Analysis
9.10.3 Segmental and Regional Analysis
9.10.4 Research & Development Expenses
9.10.5 Recent strategies and developments:
9.10.5.1 Acquisition and Mergers:
9.10.6 SWOT Analysis
List of Figures
FIG 1 Methodology for the research
FIG 2 Europe Vaccine Adjuvants Market, 2019 - 2030, USD Million
FIG 3 Key Factors Impacting the Vaccine Adjuvants Market
FIG 4 KBV Cardinal Matrix
FIG 5 Key Leading Strategies: Percentage Distribution (2019-2023)
FIG 6 Key Strategic Move: (Product Launches and Product Expansions : 2017, Jun – 2021, Jun) Leading Players
FIG 7 Porter’s Five Forces Analysis – Vaccine Adjuvants Market
FIG 8 Europe Vaccine Adjuvants Market share, by Type, 2022
FIG 9 Europe Vaccine Adjuvants Market share, by Type, 2030
FIG 10 Europe Vaccine Adjuvants Market, by Type, 2019 - 2030, USD Million
FIG 11 Europe Vaccine Adjuvants Market share, by Administration, 2022
FIG 12 Europe Vaccine Adjuvants Market share, by Administration, 2030
FIG 13 Europe Vaccine Adjuvants Market, by Administration, 2019 - 2030, USD Million
FIG 14 Europe Vaccine Adjuvants Market share, by Application, 2022
FIG 15 Europe Vaccine Adjuvants Market share, by Application, 2030
FIG 16 Europe Vaccine Adjuvants Market, by Application, 2019 - 2030, USD Million
FIG 17 Europe Vaccine Adjuvants Market share, by Country, 2022
FIG 18 Europe Vaccine Adjuvants Market share, by Country, 2030
FIG 19 Europe Vaccine Adjuvants Market, by Country, 2019 - 2030, USD Million
FIG 20 SWOT Analysis: Novavax, Inc.
FIG 21 SWOT Analysis: Agenus Inc.
FIG 22 SWOT Analysis: InvivoGen SAS
FIG 23 SWOT Analysis: Seppic S.A.
FIG 24 Recent strategies and developments: GlaxoSmithKline PLC
FIG 25 SWOT Analysis: GlaxoSmithKline PLC
FIG 26 SWOT Analysis: CSL Limited
FIG 27 SWOT Analysis: Merck & Co., Inc.
List of Tables
TABLE 1 Europe Vaccine Adjuvants Market, 2019 - 2022, USD Million
TABLE 2 Europe Vaccine Adjuvants Market, 2023 - 2030, USD Million
TABLE 3 Partnerships, Collaborations and Agreements– Vaccine Adjuvants Market
TABLE 4 Product Launches And Product Expansions– Vaccine Adjuvants Market
TABLE 5 Acquisition and Mergers– Vaccine Adjuvants Market
TABLE 6 Trials and Approvals- Vaccine Adjuvants Market
TABLE 7 Europe Vaccine Adjuvants Market, by Type, 2019 - 2022, USD Million
TABLE 8 Europe Vaccine Adjuvants Market, by Type, 2023 - 2030, USD Million
TABLE 9 Europe Particulate Market, by Country, 2019 - 2022, USD Million
TABLE 10 Europe Particulate Market, by Country, 2023 - 2030, USD Million
TABLE 11 Europe Adjuvant Emulsion Market, by Country, 2019 - 2022, USD Million
TABLE 12 Europe Adjuvant Emulsion Market, by Country, 2023 - 2030, USD Million
TABLE 13 Europe Pathogen Market, by Country, 2019 - 2022, USD Million
TABLE 14 Europe Pathogen Market, by Country, 2023 - 2030, USD Million
TABLE 15 Europe Combination Market, by Country, 2019 - 2022, USD Million
TABLE 16 Europe Combination Market, by Country, 2023 - 2030, USD Million
TABLE 17 Europe Others Market, by Country, 2019 - 2022, USD Million
TABLE 18 Europe Others Market, by Country, 2023 - 2030, USD Million
TABLE 19 Europe Vaccine Adjuvants Market, by Administration, 2019 - 2022, USD Million
TABLE 20 Europe Vaccine Adjuvants Market, by Administration, 2023 - 2030, USD Million
TABLE 21 Europe Intramuscular Market, by Country, 2019 - 2022, USD Million
TABLE 22 Europe Intramuscular Market, by Country, 2023 - 2030, USD Million
TABLE 23 Europe Intranasal Market, by Country, 2019 - 2022, USD Million
TABLE 24 Europe Intranasal Market, by Country, 2023 - 2030, USD Million
TABLE 25 Europe Oral?Market, by Country, 2019 - 2022, USD Million
TABLE 26 Europe Oral?Market, by Country, 2023 - 2030, USD Million
TABLE 27 Europe Intradermal?Market, by Country, 2019 - 2022, USD Million
TABLE 28 Europe Intradermal?Market, by Country, 2023 - 2030, USD Million
TABLE 29 Europe Others Market, by Country, 2019 - 2022, USD Million
TABLE 30 Europe Others Market, by Country, 2023 - 2030, USD Million
TABLE 31 Europe Vaccine Adjuvants Market, by Application, 2019 - 2022, USD Million
TABLE 32 Europe Vaccine Adjuvants Market, by Application, 2023 - 2030, USD Million
TABLE 33 Europe Infectious Diseases Market, by Country, 2019 - 2022, USD Million
TABLE 34 Europe Infectious Diseases Market, by Country, 2023 - 2030, USD Million
TABLE 35 Europe Cancer Market, by Country, 2019 - 2022, USD Million
TABLE 36 Europe Cancer Market, by Country, 2023 - 2030, USD Million
TABLE 37 Europe Others Market, by Country, 2019 - 2022, USD Million
TABLE 38 Europe Others Market, by Country, 2023 - 2030, USD Million
TABLE 39 Europe Vaccine Adjuvants Market, by Country, 2019 - 2022, USD Million
TABLE 40 Europe Vaccine Adjuvants Market, by Country, 2023 - 2030, USD Million
TABLE 41 Germany Vaccine Adjuvants Market, 2019 - 2022, USD Million
TABLE 42 Germany Vaccine Adjuvants Market, 2023 - 2030, USD Million
TABLE 43 Germany Vaccine Adjuvants Market, by Type, 2019 - 2022, USD Million
TABLE 44 Germany Vaccine Adjuvants Market, by Type, 2023 - 2030, USD Million
TABLE 45 Germany Vaccine Adjuvants Market, by Administration, 2019 - 2022, USD Million
TABLE 46 Germany Vaccine Adjuvants Market, by Administration, 2023 - 2030, USD Million
TABLE 47 Germany Vaccine Adjuvants Market, by Application, 2019 - 2022, USD Million
TABLE 48 Germany Vaccine Adjuvants Market, by Application, 2023 - 2030, USD Million
TABLE 49 UK Vaccine Adjuvants Market, 2019 - 2022, USD Million
TABLE 50 UK Vaccine Adjuvants Market, 2023 - 2030, USD Million
TABLE 51 UK Vaccine Adjuvants Market, by Type, 2019 - 2022, USD Million
TABLE 52 UK Vaccine Adjuvants Market, by Type, 2023 - 2030, USD Million
TABLE 53 UK Vaccine Adjuvants Market, by Administration, 2019 - 2022, USD Million
TABLE 54 UK Vaccine Adjuvants Market, by Administration, 2023 - 2030, USD Million
TABLE 55 UK Vaccine Adjuvants Market, by Application, 2019 - 2022, USD Million
TABLE 56 UK Vaccine Adjuvants Market, by Application, 2023 - 2030, USD Million
TABLE 57 France Vaccine Adjuvants Market, 2019 - 2022, USD Million
TABLE 58 France Vaccine Adjuvants Market, 2023 - 2030, USD Million
TABLE 59 France Vaccine Adjuvants Market, by Type, 2019 - 2022, USD Million
TABLE 60 France Vaccine Adjuvants Market, by Type, 2023 - 2030, USD Million
TABLE 61 France Vaccine Adjuvants Market, by Administration, 2019 - 2022, USD Million
TABLE 62 France Vaccine Adjuvants Market, by Administration, 2023 - 2030, USD Million
TABLE 63 France Vaccine Adjuvants Market, by Application, 2019 - 2022, USD Million
TABLE 64 France Vaccine Adjuvants Market, by Application, 2023 - 2030, USD Million
TABLE 65 Russia Vaccine Adjuvants Market, 2019 - 2022, USD Million
TABLE 66 Russia Vaccine Adjuvants Market, 2023 - 2030, USD Million
TABLE 67 Russia Vaccine Adjuvants Market, by Type, 2019 - 2022, USD Million
TABLE 68 Russia Vaccine Adjuvants Market, by Type, 2023 - 2030, USD Million
TABLE 69 Russia Vaccine Adjuvants Market, by Administration, 2019 - 2022, USD Million
TABLE 70 Russia Vaccine Adjuvants Market, by Administration, 2023 - 2030, USD Million
TABLE 71 Russia Vaccine Adjuvants Market, by Application, 2019 - 2022, USD Million
TABLE 72 Russia Vaccine Adjuvants Market, by Application, 2023 - 2030, USD Million
TABLE 73 Spain Vaccine Adjuvants Market, 2019 - 2022, USD Million
TABLE 74 Spain Vaccine Adjuvants Market, 2023 - 2030, USD Million
TABLE 75 Spain Vaccine Adjuvants Market, by Type, 2019 - 2022, USD Million
TABLE 76 Spain Vaccine Adjuvants Market, by Type, 2023 - 2030, USD Million
TABLE 77 Spain Vaccine Adjuvants Market, by Administration, 2019 - 2022, USD Million
TABLE 78 Spain Vaccine Adjuvants Market, by Administration, 2023 - 2030, USD Million
TABLE 79 Spain Vaccine Adjuvants Market, by Application, 2019 - 2022, USD Million
TABLE 80 Spain Vaccine Adjuvants Market, by Application, 2023 - 2030, USD Million
TABLE 81 Italy Vaccine Adjuvants Market, 2019 - 2022, USD Million
TABLE 82 Italy Vaccine Adjuvants Market, 2023 - 2030, USD Million
TABLE 83 Italy Vaccine Adjuvants Market, by Type, 2019 - 2022, USD Million
TABLE 84 Italy Vaccine Adjuvants Market, by Type, 2023 - 2030, USD Million
TABLE 85 Italy Vaccine Adjuvants Market, by Administration, 2019 - 2022, USD Million
TABLE 86 Italy Vaccine Adjuvants Market, by Administration, 2023 - 2030, USD Million
TABLE 87 Italy Vaccine Adjuvants Market, by Application, 2019 - 2022, USD Million
TABLE 88 Italy Vaccine Adjuvants Market, by Application, 2023 - 2030, USD Million
TABLE 89 Rest of Europe Vaccine Adjuvants Market, 2019 - 2022, USD Million
TABLE 90 Rest of Europe Vaccine Adjuvants Market, 2023 - 2030, USD Million
TABLE 91 Rest of Europe Vaccine Adjuvants Market, by Type, 2019 - 2022, USD Million
TABLE 92 Rest of Europe Vaccine Adjuvants Market, by Type, 2023 - 2030, USD Million
TABLE 93 Rest of Europe Vaccine Adjuvants Market, by Administration, 2019 - 2022, USD Million
TABLE 94 Rest of Europe Vaccine Adjuvants Market, by Administration, 2023 - 2030, USD Million
TABLE 95 Rest of Europe Vaccine Adjuvants Market, by Application, 2019 - 2022, USD Million
TABLE 96 Rest of Europe Vaccine Adjuvants Market, by Application, 2023 - 2030, USD Million
TABLE 97 Key Information – Novavax, Inc.
TABLE 98 Key Information – SPI Pharma, Inc.
TABLE 99 Key Information – Agenus Inc.
TABLE 100 Key Information – InvivoGen SAS
TABLE 101 Key Information – Seppic S.A.
TABLE 102 Key Information – Riboxx GmbH
TABLE 103 Key Information – GlaxoSmithKline PLC
TABLE 104 Key Information – CSL Limited
TABLE 105 Key Information – Croda International PLC
TABLE 106 Key Information - Merck & Co., Inc.